>
Switch to:

Immunogen Change In Payables And Accrued Expense

: $10.4 Mil (TTM As of Sep. 2020)
View and export this data going back to 1989. Start your Free Trial

Immunogen's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2020 was $2.8 Mil. It means Immunogen's Accounts Payable & Accrued Expense increased by $2.8 Mil from Jun. 2020 to Sep. 2020 .

Immunogen's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2019 was $-7.2 Mil. It means Immunogen's Accounts Payable & Accrued Expense declined by $7.2 Mil from Dec. 2018 to Dec. 2019 .


Immunogen Change In Payables And Accrued Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Immunogen Annual Data
Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.22 5.15 6.51 -7.19 0.00

Immunogen Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 4.60 0.39 2.81 0.00

Immunogen Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2020 was 2.618 (Dec. 2019 ) + 4.604 (Mar. 2020 ) + 0.389 (Jun. 2020 ) + 2.808 (Sep. 2020 ) = $10.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Immunogen Change In Payables And Accrued Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)